// App-Quantinova.ai

2665 : Pre-Clinical Development Of a Novel Chimerical Antigen Receptor Targeting High-Risk Pediatric ALL Over-Expressing Tslpr

Researchers

Presenter

  • Haying Qin

Principal Investigators

  • Cho Monica

  • Waleed Haso

  • Ling Zhang

  • David M. Barrett

  • Rimas J Orentas

  • Stephan A. Grupp

  • Terry J Fry

Medical Centers

  • Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA

  • Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

  • Abramson Pediatric Research Center, Childrens Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 19

  • Cluster of Differentiation 2AP

  • Cluster of differentiation 8A

  • Coxsackie Virus And Adenovirus Receptor

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved